| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| J07AL02 | PREVENAR 20 | B | Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F,8, 9V,10A, 11A, 12F, 14, 15B, 18C, 19A, 19F,22F, 23F, 33F (2.2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein (approximately 51mcg) adsorbed on aluminium phosphate (0.125mg aluminium) - | Injectable suspension | 7415106.7725 | |
| J07AL02 | VAXNEUVANCE | B | Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 22F, 23F,33F (2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg) Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate adjuvant - | Injectable suspension | 6988412.9091 | |
| J07AL01 | PNEUMOVAX 23 | B | Polysaccharides from each of 23 capsular types of Streptococcus pneumoniae - 25mcgx23serotypes/0.5ml | Injectable solution | 2378601.225 | |
| J07AJ51 | BOOSTRIX | B | Diphteria toxoid purified - ≥2.5Lf/0.5ml, Tetanus toxoid purified - ≥5Lf/0.5ml, Bordetella Pertussis Antigens: toxoid - 8mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 8mcg/0.5ml, Pertactine - 2.5mcg Al3+/0.5ml, Aluminium hydroxide - 0.3mg Al3+/0.5ml, Aluminium Phosphate - 0.2mg/0.5ml | Injectable suspension | 1394908.515 | |
| J07AH08 | MENACTRA MENINGOCOCCAL POLYSACCHARIDE DIPHTERIA TOXOID CONJUGATE VACCINE | B | Meningococcal Polysaccharides (serogroups A, C, Y and W-135) - 4mcg/0.5ml each, Diphteria Toxoid Protein - 48mcg/0.5ml | Injectable solution | 6144047.91 | |
| J07AH08 | NIMENRIX | B | Polysaccharide of Neisseria meningitidis (serogroups A, C, Y and W-135) conjugated - 5mcg/0.5ml, Tetanus toxoid carrier protein - 44mcg/0.5ml | Injectable lyophilised powder for solution+diluent | 4483058.58 | |
| J07AH08 | MENQUADFI | G | Meningococcal (serogroups A, C, W and Y) conjugate vaccine - | Injectable solution | 4859334.48 | |
| J07AH | MENFIVE | G | Meningococcal (serogroups A, C, Y, W, X) Polysaccharide conjugate vaccine - | Injectable freeze dried powder + diluent | 3527586.5625 | |
| J06BD01 | SYNAGIS | BioTech | Palivizumab - 100mg/ml | 100mg/ml | Injectable solution | 57429464.463 |
| J06BD01 | SYNAGIS | BioTech | Palivizumab - 50mg/0.5ml | 50mg/0.5ml | Injectable solution | 38316692.8872 |
| J06BB05 | RABISHIELD-100 (RABIES HUMAN MONOCLONAL ANTIBODY rDNA) | BioHuman | Rabies, Human IgG1 Monoclonal Antibody - 100IU/2.5ml | 100IU/2.5ml | 8455823.5125 | |
| J06BB04 | IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB | BioHuman | Hepatitis B immunoglobulin (human) - 100UI/ml | 100UI/ml | Injectable solution | 6853730.4656716 |
| J06BB04 | IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB | BioHuman | Hepatitis B immunoglobulin (human) - 500UI/5ml | 500UI/5ml | Injectable solution | 26599934.9952 |
| J06BB02 | TETAGAM P | BioHuman | Human Tetanus Immunoglobulin - 250IU/ml | 250IU/ml | Injectable solution | 3075475.484081 |
| J06BB02 | TETANUS GAMMA | BioHuman | Human Tetanus Immunoglobulin - 250IU/ml | 250IU/ml | Injectable solution | 3077399.325 |
| J06BB01 | IMMUNORHO | BioHuman | Human anti-D (rh) immunoglobulin - 300mcg | 300mcg | Injectable dry powder+diluent | 5794648.86 |
حمّل النسخة الجديدة من تطبيق وزارة الصحة العامة .
للحصول على آخر المستجدات حول فيروس كورونا
ستزوّدك النسخة الجديدة من تطبيق وزارة الصحة العامة بجميع المعلومات الموثوقة حول كوفيد-19، مع تحديثات مستمرة للحالات المؤكدة والبيانات. وإذا كانت لديك أي أعراض، فستكون ميزة “فحص الأعراض” دليلك للمساعدة الذاتية لتقييمها.
